Largest health care companies — Page 3
The 1,019 US-listed companies in the health care sector, ranked by market capitalisation. Sector comes from each company's Nasdaq classification; revenue and earnings come from its SEC filings.
Combined market cap
$9.815 T
10.5% of all US-listed value
Companies
1,019
Ranked #4 of 12 sectors
Average
$9.632 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 201 | Vicore Pharma Holding ABVCRE | $2.95B | $10.49 | +9.84% | Sweden |
| 202 | Adma BiologicsADMA | $2.94B | $13.24 | +26.29% | United States |
| 203 | AxogenAXGN | $2.92B | $48.92 | -4.73% | United States |
| 204 | Beam TherapeuticsBEAM | $2.68B | $25.90 | -6.82% | United States |
| 205 | ProgynyPGNY | $2.65B | $34.58 | +14.88% | United States |
| 206 | VericelVCEL | $2.65B | $51.77 | +13.83% | United States |
| 207 | Regencell BioscienceRGC | $2.61B | $5.26 | -2.95% | Hong Kong |
| 208 | Brookdale Senior LivingBKD | $2.60B | $10.90 | -2.64% | United States |
| 209 | XencorXNCR | $2.56B | $34.10 | -2.67% | United States |
| 210 | Arcus BiosciencesRCUS | $2.55B | $17.74 | -8.13% | United States |
| 211 | NeogenNEOG | $2.54B | $11.65 | -6.54% | United States |
| 212 | Zai LabZLAB | $2.54B | $22.62 | -0.79% | China |
| 213 | Pediatrix Medical GroupMD | $2.49B | $31.85 | -2.90% | United States |
| 214 | HUTCHMED (China)HCM | $2.48B | $14.20 | +2.01% | Hong Kong |
| 215 | Palvella TherapeuticsPVLA | $2.48B | $156.26 | -3.71% | United States |
| 216 | TransMedics GroupTMDX | $2.40B | $69.15 | -4.96% | United States |
| 217 | Clover Health InvestmentsCLOV | $2.38B | $4.49 | -4.37% | United States |
| 218 | Xeris BiopharmaXERS | $2.37B | $13.00 | +24.29% | United States |
| 219 | Addus HomeCareADUS | $2.36B | $126.92 | -0.80% | United States |
| 220 | MBX BiosciencesMBX | $2.34B | $48.59 | -7.41% | United States |
| 221 | Ufp TechnologiesUFPT | $2.32B | $299.11 | -9.31% | United States |
| 222 | PharvarisPHVS | $2.28B | $32.70 | -4.75% | Netherlands |
| 223 | NewAmsterdam PharmaNAMS | $2.27B | $18.90 | -9.72% | Netherlands |
| 224 | Ardent HealthARDT | $2.23B | $15.81 | +21.71% | United States |
| 225 | Celldex TherapeuticsCLDX | $2.22B | $28.32 | -5.38% | United States |
| 226 | SepternaSEPN | $2.22B | $47.51 | -0.77% | United States |
| 227 | Lakefront BiotherapeuticsLKFT | $2.22B | $33.65 | -1.29% | Belgium |
| 228 | Recursion PharmaceuticalsRXRX | $2.18B | $3.51 | -9.66% | United States |
| 229 | PERRIGOPRGO | $2.18B | $15.72 | -0.73% | United States |
| 230 | Vera TherapeuticsVERA | $2.17B | $30.18 | -5.60% | United States |
| 231 | Aurinia PharmaceuticalsAUPH | $2.17B | $16.21 | -5.29% | Canada |
| 232 | SchrodingerSDGR | $2.16B | $28.82 | +1.05% | United States |
| 233 | NeogenomicsNEO | $2.13B | $16.50 | -3.79% | United States |
| 234 | Hemab TherapeuticsCOAG | $2.13B | $45.61 | +1.15% | United States |
| 235 | ImmunomeIMNM | $2.13B | $18.04 | -7.61% | United States |
| 236 | Trulieve CannabisTRLV | $2.11B | $10.98 | -5.34% | United States |
| 237 | Prestige Consumer HealthcarePBH | $2.11B | $44.57 | -16.36% | United States |
| 238 | BiohavenBHVN | $2.09B | $13.85 | -9.15% | United States |
| 239 | ZymeworksZYME | $2.03B | $28.83 | -6.84% | United States |
| 240 | Dentsply SironaXRAY | $2.01B | $10.09 | -5.30% | United States |
| 241 | RLX TechnologyRLX | $1.98B | $1.62 | -1.22% | Cayman Islands |
| 242 | FortreaFTRE | $1.96B | $20.34 | -2.35% | United States |
| 243 | Biocryst PharmaceuticalsBCRX | $1.95B | $7.59 | -7.89% | United States |
| 244 | Inspire Medical SystemsINSP | $1.93B | $66.59 | -0.04% | United States |
| 245 | GeneDxWGS | $1.93B | $64.62 | -6.81% | United States |
| 246 | VeracyteVCYT | $1.92B | $23.88 | -54.53% | United States |
| 247 | Establishment LabsESTA | $1.92B | $64.35 | -3.87% | Costa Rica |
| 248 | First Tracks BiotherapeuticsTRAX | $1.92B | $45.58 | -7.05% | United States |
| 249 | Harmony BiosciencesHRMY | $1.91B | $32.51 | -5.54% | United States |
| 250 | Lemaitre VascularLMAT | $1.90B | $83.09 | -5.50% | United States |
| 251 | Replimune GroupREPL | $1.90B | $20.03 | -3.19% | United States |
| 252 | Vir BiotechnologyVIR | $1.89B | $11.03 | -6.29% | United States |
| 253 | agilon healthAGL | $1.88B | $112.03 | +16.42% | United States |
| 254 | Sarepta TherapeuticsSRPT | $1.85B | $17.51 | -7.79% | United States |
| 255 | Trevi TherapeuticsTRVI | $1.84B | $12.93 | -7.58% | United States |
| 256 | MesoblastMESO | $1.83B | $14.09 | -1.40% | Australia |
| 257 | Maravai LifesciencesMRVI | $1.81B | $6.97 | -9.78% | United States |
| 258 | Maze TherapeuticsMAZE | $1.80B | $32.47 | -2.73% | United States |
| 259 | AlvotechALVO | $1.78B | $4.56 | -2.35% | Luxembourg |
| 260 | Teladoc HealthTDOC | $1.72B | $9.45 | -2.63% | United States |
| 261 | Stoke TherapeuticsSTOK | $1.70B | $26.06 | -5.06% | United States |
| 262 | Zenas BioPharmaZBIO | $1.70B | $26.09 | -8.33% | United States |
| 263 | Agios PharmaceuticalsAGIO | $1.70B | $28.48 | -9.26% | United States |
| 264 | Healthcare Services GroupHCSG | $1.69B | $25.12 | -5.35% | United States |
| 265 | PersonalisPSNL | $1.69B | $15.56 | -1.49% | United States |
| 266 | Kestra Medical TechnologiesKMTS | $1.67B | $28.06 | -8.00% | United States |
| 267 | Sonida Senior LivingSNDA | $1.65B | $34.39 | -7.08% | United States |
| 268 | Generate BiomedicinesGENB | $1.64B | $12.80 | -9.61% | United States |
| 269 | EnovisENOV | $1.64B | $28.44 | +16.46% | United States |
| 270 | Nurix TherapeuticsNRIX | $1.63B | $14.88 | -6.72% | United States |
| 271 | Butterfly NetworkBFLY | $1.62B | $6.07 | -10.34% | United States |
| 272 | AbsciABSI | $1.61B | $9.39 | -10.40% | United States |
| 273 | NovavaxNVAX | $1.61B | $9.76 | -8.40% | United States |
| 274 | Ani PharmaceuticalsANIP | $1.60B | $69.62 | -2.83% | United States |
| 275 | SELLAS Life Sciences GroupSLS | $1.59B | $7.87 | -13.95% | United States |
| 276 | Ultragenyx PharmaceuticalRARE | $1.58B | $15.55 | -9.41% | United States |
| 277 | Alignment HealthcareALHC | $1.58B | $7.57 | -7.06% | United States |
| 278 | Kailera TherapeuticsKLRA | $1.58B | $12.18 | -4.84% | United States |
| 279 | NovoCureNVCR | $1.58B | $13.52 | -7.50% | Jersey |
| 280 | CONMEDCNMD | $1.57B | $52.64 | -1.90% | United States |
| 281 | Braveheart BioBRVE | $1.57B | $17.42 | -13.36% | United States |
| 282 | HerbalifeHLF | $1.57B | $14.95 | -2.35% | Cayman Islands |
| 283 | Intellia TherapeuticsNTLA | $1.56B | $11.14 | -9.54% | United States |
| 284 | TrupanionTRUP | $1.53B | $34.85 | +3.49% | United States |
| 285 | NanobiotixNBTX | $1.52B | $30.01 | +1.04% | France |
| 286 | Nuvation BioNUVB | $1.51B | $4.28 | -9.51% | United States |
| 287 | Lycia TherapeuticsLYCA | $1.50B | $28.86 | -0.21% | United States |
| 288 | PrecigenPGEN | $1.50B | $4.18 | -17.41% | United States |
| 289 | uniQureQURE | $1.47B | $20.93 | -9.12% | Netherlands |
| 290 | ImmunocoreIMCR | $1.47B | $28.51 | -2.48% | United Kingdom |
| 291 | Pacira BioSciencesPCRX | $1.45B | $36.44 | +0.10% | United States |
| 292 | U S Physical TherapyUSPH | $1.45B | $97.01 | +8.77% | United States |
| 293 | Phibro Animal HealthPAHC | $1.44B | $35.38 | -10.28% | United States |
| 294 | Tyra BiosciencesTYRA | $1.43B | $20.82 | -3.30% | United States |
| 295 | Ocular TherapeutixOCUL | $1.41B | $6.44 | -9.87% | United States |
| 296 | Ascentage Pharma Group InternationalAAPG | $1.41B | $15.13 | +0.40% | China |
| 297 | National VisionEYE | $1.41B | $17.86 | -0.47% | United States |
| 298 | Rapport TherapeuticsRAPP | $1.41B | $23.78 | -8.29% | United States |
| 299 | ADARx PharmaceuticalsADRX | $1.41B | $13.18 | -11.90% | United States |
| 300 | CadreCDRE | $1.38B | $32.19 | +4.38% | United States |
Showing 201–300 of 1,019 companies. One row per company, with secondary share classes folded into their primary listing.
Industries in Health Care
Biotechnology: Pharmaceutical Preparations 498Biotechnology: Biological Products (No Diagnostic Substances) 163Medical Specialities 43Medical/Dental Instruments 124Medicinal Chemicals and Botanical Products 26Industrial Specialties 28Other Pharmaceuticals 10Hospital/Nursing Management 14Biotechnology: Electromedical & Electrotherapeutic Apparatus 26Biotechnology: Commercial Physical & Biological Resarch 12Biotechnology: In Vitro & In Vivo Diagnostic Substances 19Medical Electronics 4Ophthalmic Goods 8Medical/Nursing Services 29Misc Health and Biotechnology Services 10Precision Instruments 3Pharmaceuticals and Biotechnology 1Managed Health Care 1
Other sectors
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.